Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04076995
Other study ID # STUDY00010276
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 18, 2019
Est. completion date December 19, 2019

Study information

Verified date February 2020
Source Arizona State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Previous studies have indicated increased vasopressin due to hypertonic saline infusion impairs glucose regulation. The current study will examine the effect of low water intake on glucose regulation. No currently published study has investigated the acute effect of low water intake on glucose regulation using continuous glucose monitoring over the course of a full day. The aim of the study is to observe the effect of low water intake on glucose regulation in low drinkers. The study will study the glycemic responses to standardized meals in adults during an 11-hour period in two conditions: a) high water intake and b) low water intake. It is hypothesized that the area under the glucose curve will be greater in the low water intake trial as compared to the high water intake trial


Recruitment information / eligibility

Status Completed
Enrollment 7
Est. completion date December 19, 2019
Est. primary completion date December 19, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 55 Years
Eligibility Inclusion Criteria:

- healthy sedentary participants

- aged 30-55 years

- body mass 27.5-35.0 kg·m2

- low water intake less than 1.5 L·day-1 (male) or 1.0 L·day-1 (female)

- 24 h urine osmolality greater than 800 mmol/kg

Exclusion Criteria:

- diabetes HbA1c >6.5%

- impaired liver or kidney function

- cardiovascular disease

- weight change of more than 3 kg in the past month

- pregnancy

- previous surgery on digestive tract

- exercise >4 h/week

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Water Intake
Increased water intake during the 11 h protocol

Locations

Country Name City State
United States Arizona Biomedical Collaborative Phoenix Arizona

Sponsors (1)

Lead Sponsor Collaborator
Arizona State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Area under the curve of Glucose at lunch 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
Primary Area under the curve of Glucose at Dinner 2-hour window starting right before dinner (4:00 pm - 6:00 pm)
Primary Area under the curve of Glucose for the entire experiment 11-hour window starting right before breakfast till 2 hours after dinner (7:00 am - 6:00 pm)
Primary Area under the curve of Copeptin for the entire experiment 11-hour window starting right before breakfast till 2 hours after dinner (7:00 am - 6:00 pm)
Primary Area under the curve of Glucagon at lunch 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
Primary Area under the curve of Glucagon at dinner 2-hour window starting right before dinner (4:00 pm - 6:00 pm)
Primary Urinary glucose excretion Entire 11-hour protocol 7:00 am - 6:00 pm
Primary Area Under the Curve for Plasma osmolality the entire 11-hour protocol 7:00 am - 6:00 pm
Secondary Area under the curve of Insulin at lunch 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
Secondary Area under the curve of Insulin at dinner 2-hour window starting right before dinner (4:00 pm - 6:00 pm)
Secondary Area under the curve of Glucagon like peptide 1 at dinner 2-hour window starting right before dinner (4:00 pm - 6:00 pm)
Secondary Area under the curve of Glucagon like peptide 1at lunch 2-hour window starting right before the lunch meal (12:00 pm - 2:00 pm)
Secondary Area under the curve of plasma cortisol the entire 11-hour protocol 7:00 am - 6:00 pm
Secondary Area under the curve for Thirst rating Thirst assessed by Visual analog scale the entire 11-hour protocol 7:00 am - 6:00 pm
Secondary Mood assessment with a questionnaire Assessed by Profile of mood state questionnaire single measurement at baseline before the beginning of breakfast at 7:00 am and 1-hour before dinner meal at 3:00 pm
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2